Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-19T06:39:59.977Z Has data issue: false hasContentIssue false
  • English
  • Français

Nosocomial Invasive Aspergillosis in Lymphoma Patients Treated with Bone Marrow or Peripheral Stem Cell Transplants

Published online by Cambridge University Press:  21 June 2016

Peter C. Iwen ,
Elizabeth C. Reed ,
James O. Armitage ,
Philip J. Bierman ,
Anne Kessinger ,
Julie M. Vose ,
Mark A. Arneson ,
Barbara A. Winfield  and
Gail L. Woods
Peter C. Iwen*
Affiliation:
Departments of Pathology and Microbiology, University of Nebraska Medical Center Omaha, Nebraska
Elizabeth C. Reed
Affiliation:
Internal Medicine, University of Nebraska Medical Center Omaha, Nebraska
James O. Armitage
Affiliation:
Internal Medicine, University of Nebraska Medical Center Omaha, Nebraska
Philip J. Bierman
Affiliation:
Internal Medicine, University of Nebraska Medical Center Omaha, Nebraska
Anne Kessinger
Affiliation:
Internal Medicine, University of Nebraska Medical Center Omaha, Nebraska
Julie M. Vose
Affiliation:
Internal Medicine, University of Nebraska Medical Center Omaha, Nebraska
Mark A. Arneson
Affiliation:
Internal Medicine, University of Nebraska Medical Center Omaha, Nebraska
Barbara A. Winfield
Affiliation:
Infection Control, University of Nebraska Medical Center Omaha, Nebraska
Gail L. Woods
Affiliation:
Departments of Anthology and Laboratory Medicine, The Medical College of Pennsylvania, Philadelphia, Pennsylvania
*
Department of Pathology and Microbiology, University of Nebraska Medical Center, 600 S. 42nd St., Omaha, NE 68198-6495
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives:

To determine the prevalence of aspergillosis in lymphoma patients housed in a protective environment while undergoing a bone marrow transplant or peripheral stem cell transplant and its relation to lymphoma type, type of transplant, period of neutropenia, method of diagnosis, species of Aspergillus, and the use of empiric amphotericin B.

Design:

Clinical, autopsy, and microbiology records were reviewed retrospectively to determine the presence or absence of invasive aspergillosis. All positive specimens underwent further review to determine parameters outlined above.

Setting:

The review took place at the University of Nebraska Medical Center with lymphoma patients housed in the oncology/hematology special care unit, which consists of 30 single-patient rooms under positive pressure with high-efficiency particulate air filtration.

Patients:

4 17 lymphoma patients admitted to the oncology/hematology special care unit who underwent 427 courses of high-dose chemotherapy with or without total body irradiation followed by a stem cell rescue.

Results:

Twenty-two cases (5.2%) of nosocomial invasive aspergillosis (14 caused by Aspergillus flavus, 2 by Aspergillus terreus, 2 by Aspergillus fumigatus, and 4 by characteristic histology) were diagnosed. The prevalence of disease according to transplant was 8.7% for allogeneic bone marrow transplant (2/23 treatments), 5.6% for autologous peripheral stem cell transplant (9/161), and 4.5% for autologous bone marrow transplant (11/243). Fifteen patients were presumptively diagnosed prior to death (68.2%) most commonly by histologic examination of skin biopsies. All 22 patients received amphotericin B therapy, 17 prior to aspergillosis diagnosis, and 7 (31.8%) survived. No patient with disseminated disease survived.

Conclusions:

Even when housing lymphoma patients undergoing myeloablative therapy in a protective environment containing high-efficiency particulate air filtration, there was a risk of developing aspergillosis. These data also showed that antemortem diagnosis with aggressive amphotericin B therapy was most effective in the management of infected lymphoma patients when engraftment occurred and the disease did not become disseminated.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 14 , Issue 3 , March 1993 , pp. 131 - 139
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1993

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Bodey, GP, Vartivarian, S. Aspergillosis. Eur J Clin Microbiol Infect Dis. 1989;8:413–437.CrossRefGoogle ScholarPubMed
2. Cordonnier, C, Bemaudin, JF, Bierling, P, Huet, Y, Vernant, JP. Pulmonary complications occurring after allogeneic bone marrow transplantation: a study of 130 consecutive transplanted patients. Cancer, 1986;58:1047–1054.3.0.CO;2-Y>CrossRefGoogle ScholarPubMed
3. Hat-a, KS, Ryu, JH, Lie, JT, Roberts, GD. Disseminated Aspergillus terreus infection in immunocompromised hosts. Mayo Clin Proc. 1989;64:770–775.Google Scholar
4. Meyers, JD, Atkinson, K. Infection in bone marrow transplantation. Ballieres Clin Haematol. 1983;12:791–811.CrossRefGoogle ScholarPubMed
5. Moore, CK, Hellreich, MA, Coblentz, CL, Roggli, VL. Aspergillus terreus as a cause of invasive pulmonary aspergillosis. Chest. 1988;94:889–891.CrossRefGoogle ScholarPubMed
6. Peterson, PK, McGlave, P, Ramsay, NKC, et al. A prospective study of infectious diseases following bone marrow transplantation: emergence of Aspergillus and Cytomegalovirus as the major causes of mortality. Infect Control. 1983;4:81–89.CrossRefGoogle ScholarPubMed
7. Rinaldi, MG. Invasive aspergillosis. Rev Infect Dis. 1983;5:1061–1077.CrossRefGoogle ScholarPubMed
8. Rotstein, C, Cummings, KM, Tidings, J, et al. An outbreak of invasive aspergillosis among allogeneic bone marrow transplants: a case-control study. Infect Control. 1985;6:347–355.CrossRefGoogle ScholarPubMed
9. Wingard, JR, Beals, SU, Santos, GW, Merz, WG, Sarai, R. Aspergil-Zus infections in bone marrow transplant recipients. Bone Marrow Transplant. 1987;2:175–181.Google ScholarPubMed
10. Woods, GL, Goldsmith, JC. Aspergillus infection of the central nervous system in patients with acquired immunodeficiency syndrome. Arch Neurol. 1990;47:181–184.CrossRefGoogle ScholarPubMed
11. Bortin, MM, Rimm, AA. Increasing utilization of bone marrow transplantation. Transplantation. 1986;42:229–234.CrossRefGoogle ScholarPubMed
12. Kessinger, A, Armitage, JO, Landmark, JD, Smith, DM, Weisenburger, DD. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Wood 1988;71:723–727.Google ScholarPubMed
13. Copelan, EA, Grever, MR, Kapoor, N, Tutschka, PJ. Marrow transplantation following busulfan and cyclophosphamide for CML in accelerated or blastic phase. Br J Haematol. 1989;71:487–491.CrossRefGoogle ScholarPubMed
14. Kessinger, A, Smith, DM, Strandjord, SE, et al. Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant. 1989;4:643–646.Google Scholar
15. Klimowski, LL, Rotstein, C, Cummings, KM. Incidence of nosocomial aspergillosis in patients with leukemia over a twenty-year period. infect Control Hosp Epidemiol. 1989;10:299–305.CrossRefGoogle Scholar
16. Vose, JM, Bierman, PJ, Weisenburger, DD, Armitage, JO. The therapy of nonHodgkin's lymphomas. Introduction and overview. Hematol Oncol Clin North Am. 1991;5:845–52.CrossRefGoogle Scholar
17. Armitage, JO, Bierman, PJ, Vose, JM. et al. Autologus bone marrow transplantation for patients with relapsed Hodgkin's disease. Am J Med. 1991:9:605–611.CrossRefGoogle Scholar
18. Armitage, JO. Bone marrow transplantation in the treatment of lymphoma. Curr Opin Oncol. 1990;2:843–848.CrossRefGoogle ScholarPubMed
19. Eder, JR Antman, K, Peters, W, et al. High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer. J Clin Oncol. 1986;4:1592–1597.CrossRefGoogle ScholarPubMed
20. Storb, R, Champlin, RE. Bone marrow transplantation for severe aplastic anemia. Bone Marrow Transplant. 1991:8:69–72.Google ScholarPubMed
21. Hobbs, JR Bone marrow transplantation for inborn errors. Lancet. 1981;2:735–739.CrossRefGoogle ScholarPubMed
22. Weems, JJ Jr, Davis, BJ, Tablan, OC, Kaufman, L, Martone, WJ. Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy. infect Control. 1987;8:71–75.CrossRefGoogle ScholarPubMed
23. Rhame, FS. Nosocomial aspergillosis: how much protection for which patients? Infect Control Hosp Epidemiol. 1989;10:296–298.CrossRefGoogle ScholarPubMed
24. Sherertz, RJ, Belani, A, Kramer, BS, et al. Impact of air filtration on nosocomial aspergillus infections. Unique risk of bone marrow transplant recipients. Am J Med. 1987;83:709–718.CrossRefGoogle ScholarPubMed
25. Rogers, TR. Prevention of infection in neutropenic bone marrow transplant patients. Antibiot Chemother. 1985;33:90–113.CrossRefGoogle ScholarPubMed
26. Iwen, PC, Davis, JC, Winfield, BA. An assessment of air quality monitoring following failure of a protective environment to prevent invasive aspergillosis in neutropenic patients during major construction. Presented at the 92nd General Meeting of the American Society for Microbiology; May 26-30, 1992: New Orleans, La.Google Scholar
27. Woods, GL, Davis, JC, Vaughan, WP. Failure of the sterile airflow component of a protective environment detected by demonstration of Chaetomium species colonization of four consecutive immunosuppressed occupants. Infect Control Hosp Epidemiol. 1988;9:451–456.CrossRefGoogle Scholar
28. Khardori, N. Host-parasite interaction in fungal infections. Eur J Clin Microbiol Infect Dis. 1989;8:331–351.CrossRefGoogle ScholarPubMed
29. Rhame, FS, Streifel, AJ, Kersey, JH Jr, McGlave, PB. Extrinsic risk factors for pneumonia in the patient at high risk of infection. Am J Med. 1984; 76(5A):42–52.CrossRefGoogle ScholarPubMed
30. Navarro, E, Lecciones, J, Witebsky, E et al. Invasive aspergillosis developing during empirical antifungal therapy. Presented at the 90th Annual Meeting of the American Society for Microbiology; May 13-17, 1990: Anaheim, Calii.Google Scholar
31. Rippon, JW. Medical Mycology The Rzthogenic Fungi and the Rzthogenic Actinomycetes. 3rd ed. Philadelphia, Pa: W.B. Saunders Co; 1988.Google Scholar
32. Shpilberg, O, Douer, D, Goldschmied-Reouven, A, et al. Invasive aspergillosis in neutropenic patients with hematological disorders. Leukemia Lymphoma. 1991;4:257–262.CrossRefGoogle ScholarPubMed
33. Fischler, D, Stoler, M, Nunez, C, Hall, G. Identification of Aspergillus sp: a comparison of culture, cytology, and surgical pathology results. Presented at the 92nd General Meeting of the American Society for Microbiology; May 26-30, 1992: New Orleans, La.Google Scholar
34. Talbot, GH, Huang, A, Provencher, M. Invasive aspergillus rhino-sinusitis in patients with acute leukemia. Rev Infect Dis. 1991;13:219–232.CrossRefGoogle Scholar
35. Allo, MD, Miller, J, Townsend, T, Tan, C. Primary cutaneous aspergillosis associated with Hickman intravenous catheters. N Engl J Med. 1987;317:1105–1108.CrossRefGoogle ScholarPubMed
36. Solomon, WR, Burge, HP Boise, JR Airbom Aspergillus fumigatus levels outside and within a large clinical center. /Allergy Clin Immunol. 1978;62:56–60.CrossRefGoogle ScholarPubMed
37. Walsh, TJ, Lee, J, Lecciones, J, et al. Empiric therapy with amphotericin B in febrile granulocytopenic patients. Rev infect Dis. 1991;13:496–503.CrossRefGoogle ScholarPubMed
38. Karp, JE, Merz, WG, Char-ache, I? Response to empiric amphotericin B during antileukemic therapy-induced granulocytopenia. Rev InfedDis. 1991;13:592–599.Google ScholarPubMed
39. Denning, DW, Stevens, DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2, 121 published cases. Rev Infect Dis. 1990;12:1147–1201.CrossRefGoogle ScholarPubMed
40. Kurup, VP, Kumar, A. Immunodiagnosis of aspergillosis. Clin Microbiol Rev. 1991;4:439–456.CrossRefGoogle ScholarPubMed
41. Vose, JM, Bierman, PJ, Kessinger, A, et al. The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies. Bane Marrow Transplant. 1991;7:139–143.Google ScholarPubMed
42. Denning, DW, Stepan, DE, Blume, KG, Stevens, DA Control of invasive pulmonary aspergillosis with oral intraconazole in a bone marrow transplant patient. J Infect. 1992;24:74–79.CrossRefGoogle Scholar